This study offers novel insights into the mechanisms by which PAH inhibits gastric cancer growth and provides a theoretical and experimental foundation for its potential as both a ferroptosis inducer and a regulator of the P62-Keap1-Nrf2 pathway. This evidence concerns the gene NFE2L2 and pulmonary arterial hypertension.